Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devico

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Virology|December 3, 2014
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesMichael A Thomas, Iskra Tuero, Thorsten Demberg, et al.
Journal of Virology|June 19, 2015
Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Neelakshi Gohain, William D Tolbert, Priyamvada Acharya, et al.
The Journal of Infectious Diseases|February 28, 2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposureJoan H Skurnick, Paul Palumbo, Anthony DeVico, et al.
Frontiers in Immunology|January 24, 2022
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1sWilliam D Tolbert, Dung N Nguyen, Marina Tuyishime, et al.
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Vaccine|June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trialJoel V Chua, Charles Davis, Jennifer S Husson, et al.
Journal of Virology|August 29, 2014
Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infectionPriyamvada Acharya, William D Tolbert, Neelakshi Gohain, et al.
Journal of Virology|May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimatesXiaoying Shen, Ryan Duffy, Robert Howington, et al.
Journal of Virology|August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene familyMattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Virology|December 3, 2014
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesMichael A Thomas, Iskra Tuero, Thorsten Demberg, et al.
Journal of Virology|June 19, 2015
Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Neelakshi Gohain, William D Tolbert, Priyamvada Acharya, et al.
The Journal of Infectious Diseases|February 28, 2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposureJoan H Skurnick, Paul Palumbo, Anthony DeVico, et al.
Frontiers in Immunology|January 24, 2022
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1sWilliam D Tolbert, Dung N Nguyen, Marina Tuyishime, et al.
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Vaccine|June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trialJoel V Chua, Charles Davis, Jennifer S Husson, et al.
Journal of Virology|August 29, 2014
Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infectionPriyamvada Acharya, William D Tolbert, Neelakshi Gohain, et al.
Journal of Virology|May 29, 2015
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman PrimatesXiaoying Shen, Ryan Duffy, Robert Howington, et al.
Journal of Virology|August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene familyMattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Pageof 13